Literature DB >> 35332094

Posterior Cingulate Involvement Does Not Argue Against LATE.

Stuart J McCarter, David T Jones, Clifford R Jack, Val Lowe, Hugo Botha1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35332094      PMCID： PMC9364354          DOI： 10.2967/jnumed.122.263968

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   11.082


× No keyword cloud information.
  9 in total

1.  Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease.

Authors:  Gaël Chételat; Rik Ossenkoppele; Victor L Villemagne; Audrey Perrotin; Brigitte Landeau; Florence Mézenge; William J Jagust; Vincent Dore; Bruce L Miller; Stéphanie Egret; William W Seeley; Wiesje M van der Flier; Renaud La Joie; David Ames; Bart N M van Berckel; Philip Scheltens; Frederik Barkhof; Christopher C Rowe; Colin L Masters; Vincent de La Sayette; Femke Bouwman; Gil D Rabinovici
Journal:  Brain       Date:  2016-06-29       Impact factor: 13.501

2.  FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis.

Authors:  Hugo Botha; William G Mantyh; Melissa E Murray; David S Knopman; Scott A Przybelski; Heather J Wiste; Jonathan Graff-Radford; Keith A Josephs; Christopher G Schwarz; Walter K Kremers; Bradley F Boeve; Ronald C Petersen; Mary M Machulda; Joseph E Parisi; Dennis W Dickson; Val Lowe; Clifford R Jack; David T Jones
Journal:  Brain       Date:  2018-04-01       Impact factor: 13.501

3.  The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.

Authors:  Seok Ming Lim; Andrew Katsifis; Victor L Villemagne; Rene Best; Gareth Jones; Michael Saling; Jennifer Bradshaw; John Merory; Michael Woodward; Malcolm Hopwood; Christopher C Rowe
Journal:  J Nucl Med       Date:  2009-09-16       Impact factor: 10.057

4.  18F-FDG PET in Posterior Cortical Atrophy and Dementia with Lewy Bodies.

Authors:  Jennifer L Whitwell; Jonathan Graff-Radford; Tarun D Singh; Daniel A Drubach; Matthew L Senjem; Anthony J Spychalla; Nirubol Tosakulwong; Val J Lowe; Keith A Josephs
Journal:  J Nucl Med       Date:  2016-09-29       Impact factor: 10.057

5.  Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer's disease?

Authors:  Stefan Teipel; Michel J Grothe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-10       Impact factor: 9.236

6.  Tau-negative amnestic dementia masquerading as Alzheimer disease dementia.

Authors:  Hugo Botha; William G Mantyh; Jonathan Graff-Radford; Mary M Machulda; Scott A Przybelski; Heather J Wiste; Matthew L Senjem; Joseph E Parisi; Ronald C Petersen; Melissa E Murray; Bradley F Boeve; Val J Lowe; David S Knopman; Clifford R Jack; David T Jones
Journal:  Neurology       Date:  2018-02-07       Impact factor: 9.910

7.  Is It Too Soon to Know When It's LATE?

Authors:  Angela C Rieger; Daniel H S Silverman
Journal:  J Nucl Med       Date:  2022-02       Impact factor: 11.082

8.  Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer's disease brain.

Authors:  Hans-Ulrich Klein; Caroline Trumpff; Hyun-Sik Yang; Annie J Lee; Martin Picard; David A Bennett; Philip L De Jager
Journal:  Mol Neurodegener       Date:  2021-11-06       Impact factor: 14.195

9.  Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy.

Authors:  Marina Buciuc; Hugo Botha; Melissa E Murray; Christopher G Schwarz; Matthew L Senjem; David T Jones; David S Knopman; Bradley F Boeve; Ronald C Petersen; Clifford R Jack; Leonard Petrucelli; Joseph E Parisi; Dennis W Dickson; Val Lowe; Jennifer L Whitwell; Keith A Josephs
Journal:  Neurology       Date:  2020-06-09       Impact factor: 9.910
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.